Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING LLC

Image Cytometry Measures Mononuclear Cell Concentration

By Labmedica International staff writers
Posted on 12 Feb 2013
A rapid fluorescence-based image cytometry system has been utilized for brightfield and fluorescence imaging analysis of cellular characteristics.

The viability and concentration of isolated peripheral blood mononuclear cells (PBMCs) are traditionally measured by manual counting with trypan blue (TB) using a hemacytometer, but red blood cell (RBC) contamination can be an issue.

Scientists at the Nexcelom Bioscience Laboratories, (Lawrence, MA, USA) compared their Cellometer Vision instrument with both manual counting and automatic method for accurately measuring the concentration of PBMCs in prepared blood samples. Fifteen freshly isolated samples were stained with acridine orange and propidium iodide (AO/PI) to identify RBC contamination. The five different methods were manual counting of TB-stained PBMCs in hemacytometer; manual counting of PBMCs in brightfield images; manual counting of acetic acid lysing of RBCs with TB-stained PBMCs; automated counting of acetic acid lysing of RBCs with PI-stained PBMCs; and AO/PI dual staining method.

Each of the 15 samples measured was categorized into low, medium, or high RBC contamination. Five samples showed less than 10% of RBC contamination, six samples showed 10% to 40% of RBC contamination, and four samples showed RBC contamination greater than 40%. The total particles counted in brightfield increased due to the addition of RBCs, while AO/PI staining showed consistent measurement of PBMCs, which again demonstrated the robustness of the method despite RBC contamination. Although inherent RBC contaminants may have existed in the sample, the purpose was to observe the increasing difference between fluorescently stained nucleated cells and total brightfield cell count including RBCs.

The authors concluded that fluorescence-based image cytometry can be utilized to eliminate the RBC-induced error in patient samples, which can improve accuracy and efficiency of PBMC measurement. Cellometer image cytometry has also demonstrated fluorescence-based cell population analysis such as apoptosis detection, cell cycle, as well as surface marker labeling. The system can be used to perform immunophenotyping of collected PBMCs, and can quickly characterize incoming patient samples, further simplifying PBMC characterization protocol. The study was published in the February 2013 issue of the Journal of Immunological Methods.

Related Links:
Nexcelom Bioscience


KARL HECHT GMBH & CO KG
77 ELEKTRONIKA
DIASYS DIAGNOSTIC SYSTEMS

Channels

Genetic Tests

view channel

Padlock Probe Assay Rapidly Detects Cardiac Disease Gene Mutations

A recent paper described a novel next generation sequencing (NGS) assay for detecting cardiac disease gene mutations with improved accuracy, flexibility, turnaround time, and cost. By using double-stranded DNA probes (complementary long "padlock" probes or cLPPs), investigators at Stanford University (Palo Alto, CA,... Read more

Hematology

view channel
Image: Immunochemistry of bone marrow biopsy from an acute myeloid leukemia patient showing sheets of CD34 positive cells; corresponding bone marrow aspirate showed only 20% blasts (Photo courtesy of All India Institute of Medical Sciences).

Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.... Read more

Industry News

view channel

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. The liquid biopsy test is based on bladder cancer DNA methylation biomarkers developed... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.